Cancer diagnoses to increase by 77% worldwide by 2050
In 2022 alone, nearly 20 million new cases of cancer were recorded
Approx. 10 million deaths due to cancer have been reported globally
A recent study conducted by the American Cancer Society has forecasted a staggering 77% increase in cancer diagnoses worldwide by the year 2050. The study attributes this surge to the extension of life expectancy, which inherently increases the likelihood of cancer development.
Advancements in medical technology have enhanced early detection capabilities, leading to both an increase in reported cancer incidences and improved treatment outcomes, as highlighted by the study. In 2022 alone, nearly 20 million new cases of cancer were recorded, resulting in approximately 10 million deaths globally.
Also read: ‘India is cancer capital of the world’: Apollo Hospitals’ Health of Nation Report
Demographic projections suggest that by 2050, the annual count of new cancer cases will reach a staggering 35 million, a phenomenon primarily driven by changes in population growth. The global population, anticipated to reach 9.7 billion by 2050, significantly contributes to the expanding cancer burden.
The study underscores the emergence of human papillomavirus (HPV) in cancer patients beyond its traditional association with cervical cancer. The HPV vaccine, recommended for preteens aged 11 to 12, stands as a crucial preventive measure against HPV-related cancers, including cervical, oropharyngeal, and anal cancers.
Investments in preventive measures targeting key risk factors such as smoking, obesity, and infections hold promise in curbing future cancer diagnoses, thereby fostering significant social and economic benefits in the coming decades, according to the American Cancer Society.
Cancer diagnoses to increase by 77% worldwide by 2050
In 2022 alone, nearly 20 million new cases of cancer were recorded
Approx. 10 million deaths due to cancer have been reported globally
A recent study conducted by the American Cancer Society has forecasted a staggering 77% increase in cancer diagnoses worldwide by the year 2050. The study attributes this surge to the extension of life expectancy, which inherently increases the likelihood of cancer development.
Advancements in medical technology have enhanced early detection capabilities, leading to both an increase in reported cancer incidences and improved treatment outcomes, as highlighted by the study. In 2022 alone, nearly 20 million new cases of cancer were recorded, resulting in approximately 10 million deaths globally.
Also read: ‘India is cancer capital of the world’: Apollo Hospitals’ Health of Nation Report
Demographic projections suggest that by 2050, the annual count of new cancer cases will reach a staggering 35 million, a phenomenon primarily driven by changes in population growth. The global population, anticipated to reach 9.7 billion by 2050, significantly contributes to the expanding cancer burden.
The study underscores the emergence of human papillomavirus (HPV) in cancer patients beyond its traditional association with cervical cancer. The HPV vaccine, recommended for preteens aged 11 to 12, stands as a crucial preventive measure against HPV-related cancers, including cervical, oropharyngeal, and anal cancers.
Investments in preventive measures targeting key risk factors such as smoking, obesity, and infections hold promise in curbing future cancer diagnoses, thereby fostering significant social and economic benefits in the coming decades, according to the American Cancer Society.